Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Arnaldi G, Masini AM, Giacchetti G, Taccaliti A, Faloia E, Mantero F (2000) Adrenal incidentaloma. Braz J Med Biol Res 33:1177–1189
Barnett CC Jr, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE (2000) Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 128:973–982; discussion 982–983
Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM (1998) Can adrenal incidentalomas be safely observed? World J Surg 22:599–603; discussion 603–604
Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M (1999) Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84:520–526
Berglund S, Hulthen UL, Manhem P (2001) Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. J Intern Med 249: 247–251
Bergstrom M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerstrom G, Langstrom B (2000) PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11Cmetomidate. J Nucl Med 41:275–282
Biersack HJ, Grunwald F (1995) Endocrinological applications in nuclear medicine. Semin Nucl Med 25:92–110
Brunt LM, Moley JF (2001) Adrenal incidentaloma. World J Surg 25:905–913
Choyke PL (1998) From needles to numbers: can noninvasive imaging distinguish benign and malignant adrenal lesions? World J Urol 16:29–34
Dackiw AP, Lee JE, Gagel RF, Evans DB (2001) Adrenal cortical carcinoma. World J Surg 25:914–926
Doppman JL (1996) Hyperaldosteronism: Sampling the adrenal veins. Radiology 198:309–312
Duh QY (2002) Adrenal incidentalomas. Br J Surg 89:1347–1349
Favia G, Lumachi F, Basso S, D’Amico DF (2000) Management of incidentally discovered adrenal masses and risk of malignancy. Surgery 128:918–924
Freitas JE, Thrall JH, Swanson DP, Rifai A, Beierwaltes WH (1975) Normal adrenal asymmetry: explanation and interpretation. J Nucl Med 19:149–154
Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A (1997) Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg 226:238–246; discussion 246–247
Geelhoed GW, Druy EM (1983) Adrenal radiography: problems and pitfalls in adrenal localization. World J Surg 7:209–222
Glazer GM (1988) MR imaging of the liver, kidneys, and adrenal glands. Radiology 166:303–312
Gross MD, Freitas JE, Swanson DP, Brady T, Beierwaltes WH (1979) The normal dexamethasone-suppression adrenal scintiscan. J Nucl Med 20:1131–1135
Gross MD, Thrall JH, Beierwaltes WH (1980) The adrenal scan: a current status report on radiotracers, dosimetry and clinical utility. Nucl Med Annual, Raven Press, New York, pp 27–175
Gross MD, Valk TW, Swanson DP, Thrall JH, Grekin RJ, Beirewaltes WH (1981) The role of pharmacologic manipulation in adrenal cortical scintigraphy. Semin Nucl Med 11:128–148
Gross MD, Shapiro B, Grekin RJ, Freitas JE, Glazer G, Beierwaltes WH, Thompson NW (1984) Scintigraphic localization of adrenal lesions in primary aldosteronism. Am J Med 77:839–844
Gross MD, Shapiro B, Bouffard JA, Glazer GM, Francis IR, Wilton GP, Khafagi F, Sonda LP (1988) Distinguishing benign from malignant euadrenal masses. Ann Intern Med 109:613–618
Gross MD, Shapiro B (1989) Scintigraphic studies in adrenal hypertension. Semin Nucl Med 19:122–143
Gross MD, Shapiro B, Francis IR, Glazer GM, Bree RL, Arcomano MA, Schteingart DE, McLeod MK, Sanfield JA, Thompson NW (1994) Scintigraphic evaluation of clinically silent adrenal masses. J Nucl Med 35:1145–1152
Gross MD, Shapiro B, Francis IR, Bree RL, Korobkin M, McLeod MK, Thompson NW, Sanfield JA (1995) Scintigraphy of incidentally discovered bilateral adrenal masses. Eur J Nucl Med 22:315–321
Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand% HS (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429
Heinz-Peer G, Honigschnabl S, Schneider B, Niederle B, Kaserer K, Lechner G (1999) Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol 173:15–22
Henry JF, Defechereux T, Gramatica L, Raffaelli M (1999) Should laparoscopic approach be proposed for large and/or potentially malignant adrenal tumors? Langenbecks Arch Surg 384:366–369
Henry JF, Sebag F, Iacobone M, Mirallie E (2002) Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg 26:1043–1047
Hönigschnabl S (2002) How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41:113–122
Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL, Reznek R, Monson JP, Besser GM, Foley R, Britton KE, Grossman AB (2001) Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86:895–902
Khafagi FA, Shapiro B, Fig LM, Mallette S, Sisson JC (1989) Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 30:481–489
Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460–484
Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, Londy F, Shapiro B, Gross MD, Thompson NW (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197:411–418
Korobkin M, Giordano TJ, Brodeur FJ, Francis R, Siegelman ES, Quint LE, Dunnick NR, Heiken JP, Wang HH (1996) Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200:743–747
Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F (1998) CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170:747–752
Kouriefs C (1999) Surgical implications of underestimation of adrenal tumour size by computed tomography. Br J Surg 86:385–387
Kouriefs C, Mokbel K, Choy C (2001) Is MRI more accurate than CT in estimating the real size of adrenal tumours? Eur J Surg Oncol 27:487–490
Krestin GP, Steinbrich W, Friedmann G (1989) Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171:675–680
Krestin GP, Freidmann G, Fishbach R, Neufang KF, Allolio B (1991) Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 15:104–110
Lau H, Lo CY, Lam KY (1999) Surgical implications of underestimation of adrenal tumour size by computed tomography. Br J Surg 86:385–387
Linos DA, Stylopoulos N (1997) How accurate is computed tomography in predicting the real size of adrenal tumors? A retrospective study. Arch Surg 132:740–743
Lockhart ME, Smith JK, Kenney PJ (2002) Imaging of adrenal masses. Eur J Radiol 41:95–112
Ludvik B, Niederle B, Roka R, Längle F, Neuhold N, Templ M, G. S (1993) Isolated primary aldosteronism in adrenocortical carcinoma: a case report and review of the literature. Acta Chir Austriaca 25:212–216
Lumachi F, Zucchetta P, Marzola MC, Bui F, Casarrubea G, Angelini F, Favia G (2002) Usefulness of CT scan, MRI and radiocholesterol scintigraphy for adrenal imaging in Cushing’s syndrome. Nucl Med Commun 23:469–473
Lumachi F, Borsato S, Tregnaghi A, Basso SM, Marchesi P, Ciarleglio F, Fassina A, Favia G (2003) CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol 29:689–692
Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW (2001) Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86:1066–1071
Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637–644
Maurea S, Mainolfi C, Bazzicalupo L, Panico MR, Imparato C, Alfano B, Ziviello M, Salvatore M (1999) Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173:25–29
Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M (2001) The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. J Nucl Med 42:884–892
Miccoli P, Raffaelli M, Berti P, Materazzi G, Massi M, Bernini G (2002) Adrenal surgery before and after the introduction of laparoscopic adrenalectomy. Br J Surg 89: 779–782
Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM (1992) Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185:345–351
Nacaudie-Calzade M, Huglo D, Lambert M (1999) Efficacy of iodine-131-6ß-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronismus. Eur J Nucl Med 26:1326–1332
Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC, Beierwaltes WH (1983) The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 24:672–682
Nakajo M, Shapiro B, Glowniak J, Sisson JC, Beierwaltes WH (1983) Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 24:1127–1134
Niederle B, Winkelbauer FW, Frilling A (1995) Inzedentaloma der Nebenniere — eine Übersicht. Chir Gastroenterol 11:34–41
Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG (1995) Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol 165:579–583
Outwater EK, Siegelman ES, Huang AB, Birnbaum BA (1996) Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200: 749–752
Pattou FN, Combemale FP, Poirette JF, Carnaille B, Wemeau JL, Huglo D, Ernst O, Proye CA (1996) Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas. Surgery 120:1006–1011; discussion 1012
Prager G, Heinz-Peer G, Passler C, Kaczirek K, Schindl M, Scheuba C, Niederle B (2002) Surgical strategy in adrenal masses. Eur J Radiol 41:70–77
Prager G, Heinz-Peer G, Passler C, Kaczirek K, Schindl M, Scheuba C, Vierhapper H, Niederle B (2002) Can dynamic gadolinium-enhanced magnetic resonance imaging with chemical shift studies predict the status of adrenal masses? World J Surg 26:958–964
Prager G, Heinz-Peer G, Passler C, Kaczirek K, Scheuba C, Niederle B (2004) Applicability of laparoscopic adrenalectomy in 150 consecutive patients — a prospective study. Arch Surg 139:46–49
Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL (1987) Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology 165:89–93
Reiners C (1994) Nebennierenrinde. In:Büll U, Schicha H, Biersack HJ, Knapp WH, Reiners C, Schober O (eds) Nuklearmedizin. Thieme, Stuttgart
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J (1996) Oncological applications of positron emission tomography with fl uorine-18 fl uorodeoxyglucose. Eur J Nucl Med 23:1641–1674
Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC (2001) Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86:1083–1090
Saeger W, Fassnacht M, Chita R, Prager G, Nies C, Lorenz K, Barlehner E, Simon D, Niederle B, Beuschlein F, Allolio B, Reincke M (2003) High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol 34:180–186
Salam Z, Lubbos H, Martinez C, Mozley PD, Miller JL, Rose LI (1996) Case report: failure of adrenal scintigraphy to exhibit 131I cholesterol uptake in a CT-demonstrated, surgically proven aldosteronoma. Am J Med Sci 312:130–132
Semelka RC, Shoenut JP, Lawrence PH, Greenberg HM, Maycher B, Madden TP, Kroeker MA (1993) Evaluation of adrenal masses with gadolinium enhancement and fatsuppressed MR imaging. J Magn Reson Imaging 3:337–343
Shapiro B, Nakajo M, Gross MD, Freitas J, Copp J, Beierwaltes WH (1983) Value of bowel preparation in adrenocortical scintigraphy with NP-59. J Nucl Med 24:732–734
Shapiro B, Grekin RJ, Gross MD, Freitas JE (1994) Interference of spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronismus. Clin Nucl Med 19:441–445
Shapiro B, Fig LM, Gross MD, Shulkin BL, Sisson JC (1998) Neuroendocrine tumors. In: Aktolun C, Tauxe WN (eds) Nuclear oncology. Springer, Tokyo, pp 3–31
Siren J, Tervahartiala P, Sivula A, Haapiainen R (2000) Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 24:579–582
Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13:513–521
Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202:517–521
Van der Harst E, De Herder WW, Bruining HA (2001) Metaiodobenzylguanidine and In-111-Octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 86:685–693
Whalen RK, Althausen AF, Daniels GH (1992) Extraadrenal pheochromocytoma. J Urol 147:1–10
Wheeler MH, Harris DA (2003) Diagnosis and management of primary aldosteronism. World J Surg 27:627–631
Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH (1980) Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 21:349–353
Wieland DM, Brown LE, Tobes MC, Rogers WL, Marsh DD, Mangner TJ, Swanson DP, Beierwaltes WH (1981) Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med 22:358–364
Young WF Jr, Hogan MJ, Klee GG, Grant CS, van Heerden JA (1990) Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 65:96–110
Young WF Jr, Stanson AW, Grant CS, Thompson GB, van Heerden JA (1996) Primary aldosteronism: adrenal venous sampling. Surgery 120:913–919; discussion 919–920
Yu KC, Alexander HR, Ziessman HA, Norton JA, Doppman JL, Buell JF, Nieman LK, Cutler GB Jr, Chrousos GP, Fraker DL (1995) Role of preoperative iodocholesterol scintiscanning in patients undergoing adrenalectomy for Cushing’s syndrome. Surgery 118:981–986; discussion 986–987
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Niederle, B., Heinz-Peer, G., Kaczirek, K., Kurtaran, A. (2005). The Value of Adrenal Imaging in Adrenal Surgery. In: Linos, D., van Heerden, J.A. (eds) Adrenal Glands. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26861-8_5
Download citation
DOI: https://doi.org/10.1007/3-540-26861-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41099-7
Online ISBN: 978-3-540-26861-1
eBook Packages: MedicineMedicine (R0)